Van Well Daan 4

What Happened
Daan Van Well, Chief Legal Officer of SOPHiA GENETICS SA (SOPH), sold 684 shares in an open-market transaction on March 19, 2026. The weighted-average sale price was $4.79 per share, for total proceeds of $3,274. This was a sale (routine liquidity) rather than a purchase.

Key Details

• Transaction date: 2026-03-19 (reported on Form 4 filed 2026-03-20)
• Transaction type/code: Sale (S) — open market
• Shares sold: 684; Weighted-average price: $4.79; Total value: $3,274
• Price range: $4.69 to $4.87 (shares sold in multiple trades; per-footnote the filer can provide per-price breakdown on request)
• Reason/footnote: Sold to satisfy tax obligations related to RSU vesting on 2026-03-18; executed under a pre-established Rule 10b5-1 trading plan (non-discretionary)
• Shares owned after transaction: Not specified in the filing
• Filing timeliness: Filed the day after the transaction; no late filing indicated

Context
This sale was executed to cover tax withholding from restricted stock unit vesting and was made under a 10b5-1 plan, which means it was pre-planned and not an ad-hoc, discretionary trade. Such sell-to-cover transactions are common and generally represent routine tax-related liquidity rather than a direct signal about executive sentiment toward the stock.